Article thumbnail
Location of Repository

Calcineurin activation influences muscle phenotype in a muscle-specific fashion

By Robert J Talmadge, Jeffrey S Otis, Matthew R Rittler, Nicole D Garcia, Shelly R Spencer, Simon J Lees and Francisco J Naya

Abstract

BACKGROUND: The calcium activated protein phosphatase 2B, also known as calcineurin, has been implicated as a cell signaling molecule involved with transduction of physiological signals (free cytosolic Ca(2+)) into molecular signals that influence the expression of phenotype-specific genes in skeletal muscle. In the present study we address the role of calcineurin in mediating adaptations in myosin heavy chain (MHC) isoform expression and muscle mass using 3-month old wild-type (WT) and transgenic mice displaying high-level expression of a constitutively active form of calcineurin (MCK-CN* mice). RESULTS: Slow muscles, e.g., soleus, were significantly larger (by ~24%), whereas fast muscles, e.g., medial gastrocnemius (MG) and tibialis anterior were significantly smaller (by ~26 and ~16%, respectively) in MCK-CN* mice compared to WT. The masses of mixed phenotype muscles, such as the plantaris and the extensor digitorum longus, were not significantly changed from WT. The soleus, plantaris, MG and diaphragm displayed shifts toward slower MHC isoforms, e.g., soleus from WT mice contained ~52% MHC-I, ~39% MHC-IIa, and ~9% MHC-IIx, whereas MCK-CN* mice had ~67% MHC-I, ~26% MHC-IIa, and ~7% MHC-IIx. The specific isoforms that were either up or down-regulated were muscle-specific. For instance, the proportion of MHC-IIa was decreased in the soleus and diaphragm, but increased in the plantaris and MG of MCK-CN* mice. Also, the proportion of MHC-IIx was unchanged in the soleus, decreased in the diaphragm and increased in the plantaris and MG of MCK-CN* relative to WT mice. Fast to slow shifts in fiber type proportions were evident for the plantaris, but not the soleus. Fast, but not slow, plantaris fibers of MCK-CN* mice had higher oxidative and lower glycolytic properties than WT. CONCLUSION: These data suggest that calcineurin activation can influence muscle phenotype and that the specific influence of calcineurin activation on the phenotypic and mass characteristics of a muscle is dependent upon the original phenotypic state of the muscle

Topics: Research Article
Publisher: BioMed Central
Year: 2004
DOI identifier: 10.1186/1471-2121-5-28
OAI identifier: oai:pubmedcentral.nih.gov:509416
Provided by: PubMed Central

Suggested articles

Citations

  1. (1986). All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science
  2. (1999). Bed rest increases the amount o f m i s m a t c h e d f i b e r s i n human skeletal muscle.
  3. (2004). BJ: Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet
  4. (2001). Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth.
  5. (2000). CB: Calcineurin: from structure to function. Curr Top Cell Regul
  6. (2001). Different pathways regulate expression of the skeletal myosin heavy chain genes.
  7. (1992). EA: FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature
  8. (1999). Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell
  9. (2001). Glass DJ: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/ GSK3 pathways. Nat Cell Biol
  10. (2001). HP: Calcineurin regulates slow myosin, but not fast myosin or metabolic enzymes, during fast-to-slow transformation in rabbit skeletal muscle cell culture.
  11. (2000). Ishihara A: Cell size and oxidative enzyme activity of different types of fibers in different regions of the rat plantaris and tibialis anterior muscles.
  12. (1999). Ishihara A: Succinate dehydrogenase activities of fibers in the rat extensor digitorum longus, soleus, and cardiac muscles. Arch Histol Cytol
  13. (1998). KM: Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading.
  14. (1990). Lomo T: Expression of myosin heavy chain isoforms in stimulated fast and slow rat muscles.
  15. (2000). Molkentin JD: A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol
  16. (2003). Molkentin JD: Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta genetargeted mice. Mol Cell Biol
  17. (2000). Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve
  18. (1999). N: IGF-1 induces skeletal myocyte hypertrophy through calcineurin
  19. (2000). Olson EN: Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.
  20. (2002). Pavlath GK: Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles.
  21. (1997). PG: Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol
  22. (1999). RN: Calcineurin is required for skeletal muscle hypertrophy.
  23. (2000). RN: Matching of calcineurin activity to upstream effectors is critical for skeletal muscle fiber growth.
  24. (1993). RR: Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms.
  25. (1998). RS: A calcineurindependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev
  26. (2001). RS: Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.
  27. (2000). RS: MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.
  28. (2000). SC: The calcineurin-NFAT pathway and muscle fiber-type gene expression.
  29. (1999). Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature
  30. (2003). Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways.
  31. (1997). Staron RS: Mammalian skeletal muscle fiber type transitions. Int Rev Cytol
  32. (2001). Talmadge RJ: Skeletal muscle calcineurin: influence of phenotype adaptation and atrophy.
  33. (2004). Tsika RW, Molkentin JD: Genetic loss of calcineurin blocks mechanical overloadinduced skeletal muscle fiber type switching but not hypertrophy.
  34. (2000). VenturaClapier R: Calcineurin Co-regulates contractile and metabolic components of slow muscle phenotype.
  35. (1996). VR: Distribution of myosin heavy chain isoforms in non-weight-bearing rat soleus muscle fibers.
  36. (1998). VR: Effects of inactivity on myosin heavy chain composition and size of rat soleus fibers. Muscle Nerve
  37. (1998). VR: Fibre size and metabolic properties of myosin heavy chain-based fibre types in rat skeletal muscle.
  38. (1999). VR: Interrelationships of myofibrillar ATPase activity and metabolic properties of myosin heavy chain-based fibre types in rat skeletal muscle. Histochem Cell Biol
  39. (1999). VR: Persistence of hybrid fibers in rat soleus after spinal cord transection. Anat Rec
  40. (1995). VR: Prominence of myosin heavy chain hybrid fibers in soleus muscle of spinal cord-transected rats.
  41. (1992). Vrbova G: Adaptation of mammalian skeletal muscle fibers to chronic electrical stimulation. Rev Physiol Biochem Pharmacol
  42. (2001). Yancopoulos GD: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.